-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.Börse Börse FrankfurtSymbol AJ81-
Agenus IncBörse Börse FrankfurtSymbol AJ81
-
AGENUS INCBörse Gettex System der Börse MünchenSymbol AJ81
-
AGENUS INCBörse Quotrix System der Börse DüsseldorfSymbol AJ81
-
AGENUS INCBörse Tradegate System der Deutsche Börse AG (60%)Symbol AJ81
-
AGENUS INCBörse Börse MünchenSymbol AJ81
-
AGENUS INCBörse Börse BerlinSymbol AJ81
-
AGENUS INCBörse Börse DüsseldorfSymbol AJ81
-
ISIN US00847G7051 WKN: A1JLKZSymbol AGEN
-
ISIN US00847G7051
-
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
859.473.472 oder 1.064.000.000
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
328 oder 533 Mitarbeiter
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 2,43 EUR +1,20%
6 ETFs die in Agenus investieren
Dir gefallen die Informationen zu Agenus?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Dir gefallen die Informationen zu Agenus?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Dir gefallen die Informationen zu Agenus?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Dir gefallen die Informationen zu Agenus?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
29 News & Informationen zur Agenus Aktie
Stocks That Hit 52-Week Highs On Friday
Before 10 a.m. ET Friday, 183 stocks hit new 52-week highs.
Areas of Significance: Alphabet (NASDAQ:GOOG) was the biggest firm by market cap …
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Au…
Balstilimab Monotherapy Data Published in Gynecologic Oncology
Objective response rate of 20% and median duration of response not reached with 14.6 month median follow-up in PD-L1+ tumorsResponses seen across all…
Agenus' Data Release And MiNK IPO Should Lead To Valuation Gains (NASDAQ:AGEN)
In Q42021 (likely at SITC), AGEN is anticipated to publish updated 1181/Bal Phase 2 clinical data in MSS-CRC that shows 1181/Bal significantly outperforms current FDA approved 3rd line…
Oracle Investment Management Inc Buys Vir Biotechnology Inc, Forian Inc, SPDR Biotech ETF, Sells Quidel Corp, Amarin Corp PLC, Select Medical Holdings Corp
GuruFocus Article or News written by insider and the topic is about:
Investors Cheer As Agenus Chugs Along
Shares of Agenus Inc. (AGEN), which have nearly doubled in value year-to-date, trade around $6..
5 Biotech Stocks Popular On Reddit
Agenus Inc. (NASDAQ: AGEN) ranks 5th on the list of 11 biotech stocks popular on Reddit. The Massachusetts-based biotech firm develops immuno-oncology therapeutics.
Agenus Multiple Value-Adding Events Ahead (NASDAQ:AGEN)
Agenus has little product royalty revenue but a large pipeline of potential therapies. Read more to know why I’m very optimistic about AGEN stock going forward.
OncXerna Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer
WALTHAM, Mass., Aug. 17, 2021 (GLOBE NEWSWIRE) — OncXerna Therapeutics, Inc. (“OncXerna”), a precision medicine company using an innovative…
Stocks That Hit 52-Week Highs On Monday
Before 10 a.m. ET on Monday, 71 companies hit new 52-week highs.
Highlights: Apple (NASDAQ:AAPL) was the largest firm on a market cap basis to …
Stocks That Hit 52-Week Highs On Friday
During Friday's morning session, 137 companies made new 52-week highs.
Areas of Significance: Johnson & Johnson (NYSE:JNJ) was the …
Stocks That Hit 52-Week Highs On Thursday
Thursday's morning session saw 119 companies set new 52-week highs.
Areas of Significance: Wells Fargo (NYSE:WFC) was the largest company by …
Hot Biotech Stocks That Deserve Your Attention In August 2021
Hot Biotech Stocks That Deserve Your Attention In August 2021
Is it time to add biotech stocks to your list this year?
Agenus shares fall on Q2 earnings miss, cash position update (NASDAQ:AGEN)
Agenus (AGEN) shares traded 4% lower before the bell on Monday as the company posted second-quarter results that missed Wall Street estimates, and provided an update on the company's…
Agenus EPS misses by $0.13, misses on revenue (NASDAQ:AGEN)
Agenus (AGEN): Q2 GAAP EPS of -$0.37 misses by $0.13.Revenue of $10.73M (-60.2% Y/Y) misses by $9.68M.Press Release
Agenus Corporate Update and Second Quarter 2021 Financial Report
$200M received from BMS for anti-TIGIT bispecific antibody collaborationFDA cleared IND for AGEN1777 clinical enrollmentAGEN1181 rapidly advancing in the…
Earnings Scheduled For August 9, 2021
Companies Reporting Before The Bell
• Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of …
Agenus Q2 Earnings Preview (NASDAQ:AGEN)
Agenus (NASDAQ:AGEN) is scheduled to announce Q2 earnings results on Monday, August 9th, before market open.The consensus EPS Estimate is -$0.24 (+14.3% Y/Y) and the consensus…
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnin…
Is Aldeyra Therapeutics Inc (ALDX) A Good Stock To Buy?
A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors…
Why Agenus Stock Sank on Tuesday
A top company executive is stepping down in the very near future.
What Makes Agenus (AGEN) a Good Fit for “Trend Investing”
Agenus (AGEN) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our “Recent Price Strength” screen.
Agenus Acquires 120 Acres in the Heart of the California Biomanufacturing Center in Vacaville
VACAVILLE, Calif., July 09, 2021 (GLOBE NEWSWIRE) — Agenus Inc. has purchased 120-acres in Vacaville’s California Biomanufacturing Center from housing…
Agenus to Participate in Resistance-Focused Oncology Panel at the William Blair Biotech Focus Conference 2021
LEXINGTON, Mass., July 07, 2021 — Agenus , an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate… | July 7, 2021
Agenus Closes $200M Upfront BMS Collaboration and Announces FDA Acceptance of IND for Partnered Anti-TIGIT Bispecific Antibody, AGEN1777
LEXINGTON, Mass., July 06, 2021 — Agenus Inc. , an immuno-oncology company with an extensive pipeline of agents which includes checkpoint antibodies, cell therapies, adjuvants, and vaccines… | July 6, 2021
Eyes Shift to the Healthcare Industry After the Pandemic Prompts a Reconsideration
NEW YORK, July 2, 2021 /PRNewswire/ — While the economy is slowly coming back to normal, concerns over the hyper-transmissible delta variant are rising. According to the CDC, the number of new…
Agenus (NASDAQ:AGEN) Stock: What Now
Agenus Inc. recently signed a collaboration agreement with BMY that has helped spark a large rally in the stock. See here why a covered call strategy is a good way to play this stock now.
Agenus 1181 New Cancer Response Data Adds To Conviction (NASDAQ:AGEN)
While there are risks, I believe if Agenus can get past the usual hurdles with all of its candidates, it can generate over a billion dollars in annual revenue by the middle of this decade.